Intra-arterial thrombolysis in 24 consecutive patients with internal carotid artery T occlusions

Objectives: To determine the safety, efficacy, and predictors of favourable outcome of intra-arterial thrombolysis in acute stroke attributable to internal carotid “T”occlusion Methods: The authors analysed 24 consecutive patients with T occlusions of the internal carotid artery treated by local intra-arterial thrombolysis using urokinase. Results: The median baseline National Institutes of Health Stroke Scale was 19. The average time from symptom onset to treatment was 237 minutes. Four patients (16.6%) had a favourable (modified Rankin Scale score (mRS⩽2)) and 10 patients (41.7%) a poor outcome (mRS 3 or 4) after three months. Ten patients (41.7%) died. One symptomatic intracerebral haemorrhage (4.2%) occurred. Partial recanalisation of the intracranial internal carotid artery was achieved in 15 (63%), of the middle cerebral artery in four (17%), and of the anterior cerebral artery in eight patients (33%). Complete recanalisation never occurred. Sufficient leptomeningeal collaterals as seen on arteriography (p=0.02) and age <60 years (p=0.012) were the only predictors of favourable clinical outcome. Conclusions: Acute stroke attributable to carotid T occlusion remains a condition with a generally poor prognosis even when intra-arterial thrombolysis is performed. Favourable outcome was seen only in patients with sufficient leptomeningeal collaterals.

[1]  A. Thie,et al.  Local intra-arterial fibrinolytic therapy in patients with stroke: urokinase versus recombinant tissue plasminogen activator (r-TPA) , 2004, Neuroradiology.

[2]  A. Alexandrov,et al.  Intracranial balloon angioplasty of acute terminal internal carotid artery occlusions. , 2002, AJNR. American journal of neuroradiology.

[3]  J. Sunshine,et al.  Response to Intra-Arterial and Combined Intravenous and Intra-Arterial Thrombolytic Therapy in Patients With Distal Internal Carotid Artery Occlusion , 2002, Stroke.

[4]  M. Jan,et al.  Recombinant tissue plasminogen activator for acute ischemic stroke. , 2002, Saudi medical journal.

[5]  V. Keris,et al.  Combined intraarterial/intravenous thrombolysis for acute ischemic stroke. , 2001, AJNR. American journal of neuroradiology.

[6]  J. Broderick,et al.  Combined Intravenous and Intra-Arterial Recombinant Tissue Plasminogen Activator in Acute Ischemic Stroke , 2000, Stroke.

[7]  D. Tirschwell,et al.  Intra-arterial prourokinase for acute ischemic stroke. , 2000, JAMA.

[8]  M. Grond,et al.  Intra-arterial prourokinase for acute ischemic stroke. , 2000, JAMA.

[9]  P. Akins,et al.  Intra-arterial prourokinase for acute ischemic stroke. , 2000, JAMA.

[10]  G. Albers,et al.  Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke. , 1999, JAMA.

[11]  S. Ohta,et al.  Multivariable analysis of predictive factors related to outcome at 6 months after intra-arterial thrombolysis for acute ischemic stroke. , 1999, Stroke.

[12]  Wei Li,et al.  Thrombolysis with intravenous rtPA in a series of 100 cases of acute carotid territory stroke: determination of etiological, topographic, and radiological outcome factors. , 1998, Stroke.

[13]  GerhardSchroth,et al.  Local Intra-Arterial Thrombolysis in Acute Ischemic Stroke , 1998 .

[14]  G. Schroth,et al.  Local intra-arterial thrombolysis in acute ischemic stroke. , 1998, Stroke.

[15]  U. Grzyska,et al.  The predictive value of early CT and angiography for fatal hemispheric swelling in acute stroke. , 1998, AJNR. American journal of neuroradiology.

[16]  M. Kaste,et al.  [Thrombolytic therapy of basilar artery occlusion]. , 1998, Duodecim; laaketieteellinen aikakauskirja.

[17]  L Bozzao,et al.  Acute stroke: usefulness of early CT findings before thrombolytic therapy. , 1997, Radiology.

[18]  H. Urbach,et al.  Local intra-arterial fibrinolysis in thromboembolic “T” occlusions of the internal carotid artery , 1997, Neuroradiology.

[19]  The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. International Stroke Trial Collaborative Group. , 1997, Lancet.

[20]  T. N. t-P. S. S. Group,et al.  Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke. The NINDS t-PA Stroke Study Group. , 1997, Stroke.

[21]  W. Hacke,et al.  Thrombolytic therapy of acute basilar artery occlusion. Variables affecting recanalization and outcome. , 1996, Stroke.

[22]  W. Hacke,et al.  Thrombolytic therapy in acute occlusion of the intracranial internal carotid artery bifurcation. , 1995, AJNR. American journal of neuroradiology.

[23]  P. Bollaert,et al.  Early local intra-arterial thrombolysis for severe middle cerebral artery stroke , 1995 .

[24]  W. Hacke,et al.  Does arterial recanalization improve outcome in carotid territory stroke? , 1995, Stroke.

[25]  T. Koike,et al.  Fibrinolytic therapy for acute embolic stroke: intravenous, intracarotid, and intra-arterial local approaches. , 1995, Neurosurgery.

[26]  David Lee Gordon,et al.  Classification of Subtype of Acute Ischemic Stroke: Definitions for Use in a Multicenter Clinical Trial , 1993, Stroke.

[27]  C. Weiller,et al.  Type and extent of hemispheric brain infarctions and clinical outcome in early and delayed middle cerebral artery recanalization , 1992, Neurology.

[28]  J. Marler,et al.  Measurements of acute cerebral infarction: a clinical examination scale. , 1989, Stroke.

[29]  J. Slattery,et al.  Interobserver agreement for the assessment of handicap in stroke patients. , 1989, Stroke.

[30]  H. Schouten,et al.  Interobserver agreement for the assessment of handicap in stroke patients. , 1988, Stroke.

[31]  H. S. Mueller,et al.  The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings. , 1985, The New England journal of medicine.